CRISPR Therapeutics AG — Form D/A

CRISPR Therapeutics AG of Zug, V6, a company, filed a Form D amendment with the SEC on 2020-04-10. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Other Health Care.

Offering

Filed: 2020-04-10
Form: D/A
Accession: 0001209191-20-024107
Industry: Other Health Care
Exemptions: 06b
Total offering: $1.0M
Amount sold: $1.0M
Investors: 1
Date of first sale: 2020-03-11
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-364701

Issuer

Name: CRISPR Therapeutics AG
CIK: 0001674416
Entity type: Corporation
Jurisdiction: SWITZERLAND
Incorporated: 2013
Address: Baarerstrasse 14, Zug, V6, 6300
Phone: +41 (0)41 561 32 77

Officers, directors & promoters (25)

Name	Role	Location
Ali Behbahani	Director	Littleton, CO
Bradley Bolzon	Director	SAN DIEGO, CA
Simeon George	Director	Redwood City, CA
John Greene	Director	Scottsdale, AZ
Katherine High	Director	Zug, V8
Samarth Kulkarni	Director	Zug, V8
Rodger Novak	Director	Zug, V8
Tony Ho	Executive Officer	Charlestown, MA
James Kasinger	Executive Officer	Zug, V8
Lawrence Klein	Executive Officer	Zug, V8
Samarth Kulkarni	Executive Officer	Zug, V8
Rodger Novak	Executive Officer	Zug, V8
Michael Tomsicek	Executive Officer	Zug, V8
Simeon J George	Director	Wayne, PA
N. Anthony Coles	Director	Boston, MA
Thomas J Woiwode	Director	San Francisco, CA
Kurt J von Emster	Director	Basel, V8
Sven Ante Lundberg	Executive Officer	Cambridge, MA
Ali Anthony Behbahani	Director	Basel, V8
Pablo J Cagnoni	Director	Basel, V8
Bradley Anthony Bolzon	Director	Basel, V8
Kala Ante Subramanian	Executive Officer	Cambridge, MA
Samarth Ante Kulkarni	Executive Officer	Cambridge, MA
Marc J Becker	Executive Officer	Cambridge, MA
Tyler Ante Dylan-Hyde	Executive Officer	Cambridge, MA

Other filings by this issuer (2)

Filed	Form	Offering	Sold
2020-04-09	D	$1.0M	$1.0M
2016-11-04	D	$35.0M	$35.0M

CRISPR Therapeutics AG — Form D/A

Offering

Issuer

Officers, directors & promoters (25)

Other filings by this issuer (2)

More